| Revenues | | 1,805.64 | 1,685.63 | 1,581.38 | 1,529.44 |
| Cost Of Revenue | | 1,125.70 | 1,062.81 | 1,002.18 | 983.29 |
| | 267.64 | - | - | - |
| Selling, General, and Administrative | | 267.64 | - | - | - |
| Research and Development | | 185.99 | - | - | - |
| Costs And Expenses | | 1,621.29 | 1,517.64 | 1,364.49 | 1,592.85 |
| Income/Loss From Equity Method Investments | | 0.02 | 0.06 | 0.22 | 0.69 |
| Income/Loss From Continuing Operations Before Tax | | 184.35 | 167.99 | 216.89 | -63.42 |
| Income Tax Expense/Benefit | | 2.67 | 24.17 | -8.31 | 34.70 |
| | 181.67 | 143.81 | 225.20 | -98.11 |
| Attributable To Parent | | 191.40 | 146.72 | 226.35 | -95.62 |
| Available To Common Stockholders, Basic | | 191.40 | 145.09 | 192.87 | -128.76 |
| Preferred Stock Dividends And Other Adjustments | - | - | 1.62 | 33.48 | 33.14 |
| Attributable To Noncontrolling Interest | | -9.73 | -2.90 | -1.15 | -2.49 |
